Dr Ebsworth has served as Non-Executive Chairperson of our board of directors since December 2014.
Dr Ebsworth has significant experience in leadership and management of pharma and biotech companies internationally. Dr Ebsworth currently serves on the boards of Sartorius and Synlab. From 2009 to 2014, Dr Ebsworth served as Chief Executive Officer of Vifor Pharma, based in Zürich, the specialty pharma division of Galenica AG Group, a pharmaceutical wholesaler and retailer, and as a member of Galenica’s Executive Committee. In 2012, Dr Ebsworth was also named as Chief Executive Officer of Galenica and as Chairman of Galenica’s Executive Committee, positions he held until 2014. In his earlier career, Dr Ebsworth worked with Bayer for over 19 years, heading the Canadian, North American and global pharmaceutical business. Dr Ebsworth received a PhD in industrial relations from the University of Surrey.
Ms Deschamps has served as a Non-Executive Director on our board of directors since March 2021.
Ms Deschamps is CEO and executive board member of AviadoBIO, a private gene therapy company. Prior to joining AviadoBIO, she was Senior Vice President and Chief Business Officer, of Novartis Gene Therapies and previously was Head of Novartis’ Global Neuroscience Franchise. During her 25-year career at Novartis, Ms Deschamps gained significant global and US experience in bringing respiratory and other specialized therapeutic area products from the clinic to commercialization. Ms Deschamps has an MBA in General Management from NYU Stern School of Business and a BBA in marketing from IONA College, Hagan School of Business.
Mr Sinha has served as a Non-Executive Director on our board of directors since September 2016.
Mr Sinha has over 20 years of experience working in executive finance roles in the life sciences industry. Mr Sinha is Chief Financial Officer and co-founder of ElevateBio, a holding company focused on building cell and gene therapy companies. He also serves as President and Chief Financial Officer of AlloVir, an ElevateBio portfolio company. In addition, Mr Sinha serves as a member of the board of directors of Allovir. From 2005 to 2016, he was the Chief Financial Officer of Alexion Pharmaceuticals. Prior to joining Alexion, Mr. Sinha held various positions with Bayer across the world including CFO, Bayer North America and CFO Bayer Yakuhin, Japan. Mr Sinha holds an MBA in business administration from the Asian Institute of Management. He is a qualified Chartered Accountant from the Institute of Chartered Accountants of India and a Certified Public Accountant in the US.
